Relationship between left ventricular diastolic relaxation and systolic function in hypertension: The Hypertension

J N Bella1, V Palmieri, J E Liu

  • 1New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY 10021, USA.

Insights

In hypertension, impaired left ventricular relaxation is linked to midwall dysfunction, not overall systolic function. This finding highlights a specific type of heart muscle abnormality in hypertensive individuals.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • The relationship between impaired left ventricular relaxation and systolic function in hypertension is not well-established in population studies.
  • Hypertension can lead to structural and functional changes in the left ventricle.

Purpose of the Study:

  • To investigate the association between impaired left ventricular relaxation and systolic function in hypertensive individuals.
  • To determine if prolonged isovolumic relaxation time in hypertension correlates with specific measures of systolic performance.

Main Methods:

  • Analysis of echocardiograms from 1457 hypertensive participants in the HyperGEN Study.
  • Exclusion criteria included diabetes, significant valvular regurgitation, and coronary disease.
  • Assessment of left ventricular relaxation (isovolumic relaxation time) and various systolic function parameters.

Main Results:

  • 15% of participants had impaired relaxation (isovolumic relaxation time >100 ms), characterized by older age and higher arterial pressure.
  • Impaired relaxation was associated with increased ventricular size, wall thickness, mass, and relative wall thickness.
  • Lower stress-corrected midwall shortening was observed in those with impaired relaxation, and this correlated inversely with prolonged isovolumic relaxation time.
  • Neither ejection fraction nor end-systolic stress/end-systolic volume index differed significantly or showed independent relationships with isovolumic relaxation time.

Conclusions:

  • Impaired left ventricular relaxation in hypertension is associated with midwall systolic dysfunction, not global systolic chamber dysfunction.
  • The findings suggest that diastolic abnormalities in hypertension may coexist with specific regional systolic impairments.
  • Further research is needed to ascertain if this combined diastolic and systolic dysfunction pattern predicts cardiovascular events in hypertensive patients.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...